Peng Zhou

Prof. Dr. Peng Zhou

Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2020 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
ZSZhengli Shi
Zhengli Shi
HGHua Guo
Hua Guo
PZPeng Zhou
Peng Zhou
ZSZhengli Shi
Zhengli Shi

1 January 2020 in Emerging Microbes & Infections
Verified
Journal Article
Open access
WZWei Zhang
Wei Zhang
RDRong-Hui Du
Rong-Hui Du
BLBei Li
Bei Li
XZXiao-Shuang Zheng
Xiao-Shuang Zheng
XYXing-Lou Yang
Xing-Lou Yang
PZPeng Zhou
Peng Zhou
In December 2019, a novel coronavirus (2019-nCoV) caused an outbreak in Wuhan, China, and soon spread to other parts of the world. It was believed that 2019-nCoV was transmitted through respiratory tract and then induced pneumonia, thus molecular diagnosis based on oral swabs was used for confirmation of this disease. Likewise, patient will be released upon two times of negative detection from oral swabs. However, many coronaviruses can also be transmitted through oral–fecal route by infecting intestines. Whether 2019-nCoV infected patients also carry virus in other organs like intestine need to be tested. We conducted investigation on patients in a local hospital who were infected with this virus. We found the presence of 2019-nCoV in anal swabs and blood as well, and more anal swab positives than oral swab positives in a later stage of infection, suggesting shedding and thereby transmitted through oral–fecal route. We also showed serology test can improve detection positive rate thus should be used in future epidemiology. Our report provides a cautionary warning that 2019-nCoV may be shed through multiple routes.

2 March 2019 in Viruses
Verified
Journal Article
Open access
PDF file
YFYi Fan
Yi Fan
KZKai Zhao
Kai Zhao
ZSZhengli Shi
Zhengli Shi
PZPeng Zhou
Peng Zhou
During the past two decades, three zoonotic coronaviruses have been identified as the cause of large-scale disease outbreaks–Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Swine Acute Diarrhea Syndrome (SADS). SARS and MERS emerged in 2003 and 2012, respectively, and caused a worldwide pandemic that claimed thousands of human lives, while SADS struck the swine industry in 2017. They have common characteristics, such as they are all highly pathogenic to humans or livestock, their agents originated from bats, and two of them originated in China. Thus, it is highly likely that future SARS- or MERS-like coronavirus outbreaks will originate from bats, and there is an increased probability that this will occur in China. Therefore, the investigation of bat coronaviruses becomes an urgent issue for the detection of early warning signs, which in turn minimizes the impact of such future outbreaks in China. The purpose of the review is to summarize the current knowledge on viral diversity, reservoir hosts, and the geographical distributions of bat coronaviruses in China, and eventually we aim to predict virus hotspots and their cross-species transmission potential.

9 October 2020 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
SLShufen Li
Shufen Li
YZYulan Zhang
Yulan Zhang
ZGZhenqiong Guan
Zhenqiong Guan
HLHuiling Li
Huiling Li
MYMeidi Ye
Meidi Ye
Ke PengKe Peng
Ke Peng
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to respiratory illness and multi-organ failure in critically ill patients. Although the virus-induced lung damage and inflammatory cytokine storm are believed to be directly associated with coronavirus disease 2019 (COVID-19) clinical manifestations, the underlying mechanisms of virus-triggered inflammatory responses are currently unknown. Here we report that SARS-CoV-2 infection activates caspase-8 to trigger cell apoptosis and inflammatory cytokine processing in the lung epithelial cells. The processed inflammatory cytokines are released through the virus-induced necroptosis pathway. Virus-induced apoptosis, necroptosis, and inflammation activation were also observed in the lung sections of SARS-CoV-2-infected HFH4-hACE2 transgenic mouse model, a valid model for studying SARS-CoV-2 pathogenesis. Furthermore, analysis of the postmortem lung sections of fatal COVID-19 patients revealed not only apoptosis and necroptosis but also massive inflammatory cell infiltration, necrotic cell debris, and pulmonary interstitial fibrosis, typical of immune pathogenesis in the lung. The SARS-CoV-2 infection triggered a dual mode of cell death pathways and caspase-8-dependent inflammatory responses may lead to the lung damage in the COVID-19 patients. These discoveries might assist the development of therapeutic strategies to treat COVID-19.

1 March 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
JXJiazheng Xie
Jiazheng Xie
YLYang Li
Yang Li
XSXurui Shen
Xurui Shen
GGGeraldine Goh
Geraldine Goh
YZYan Zhu
Yan Zhu
PZPeng Zhou
Peng Zhou

23 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
PZPeng Zhou
Peng Zhou
XYxinglou yang
xinglou yang
XWXian-Guang Wang
Xian-Guang Wang
ZSZhengli Shi
Zhengli Shi
LZLei Zhang
Lei Zhang
ZSZhengli Shi
Zhengli Shi
Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome related coronaviruses (SARSr-CoV) have been discovered in their natural reservoir host, bats. Previous studies indicated that some of those bat SARSr-CoVs have the potential to infect humans. Here we report the identification and characterization of a novel coronavirus (nCoV-2019) which caused an epidemic of acute respiratory syndrome in humans, in Wuhan, China. The epidemic, started from December 12th, 2019, has caused 198 laboratory confirmed infections with three fatal cases by January 20th, 2020. Full-length genome sequences were obtained from five patients at the early stage of the outbreak. They are almost identical to each other and share 79.5% sequence identify to SARS-CoV. Furthermore, it was found that nCoV-2019 is 96% identical at the whole genome level to a bat coronavirus. The pairwise protein sequence analysis of seven conserved non-structural proteins show that this virus belongs to the species of SARSr-CoV. The nCoV-2019 virus was then isolated from the bronchoalveolar lavage fluid of a critically ill patient, which can be neutralized by sera from several patients. Importantly, we have confirmed that this novel CoV uses the same cell entry receptor, ACE2, as SARS-CoV.